The association between genetically predicted circulating CRP levels and prostate cancer risk did not change markedly after excluding these outlier SNPs (OR 1.02, 95% CI 0.95 to 1.08, and P = 0.64). This evidence concerns the gene CRP and Familial prostate cancer.